background image

Paid Clinical Trials Boston

Discover 2,973 paid clinical trials in Boston, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)

Recruiting
PHASE3

Sponsor:

AbbVie

Location:

Boston, Philadelphia, Washington, Charlotteshow 7 more

Code:

NCT04064827

Conditions

Chronic Kidney Disease (CKD)

Secondary Hyperparathyroidism (SHPT)

Eligibility Criteria

Sex: All

Age: 0 - 9

Healthy Volunteers: Not accepted

Interventions

Paricalcitol

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia

Recruiting

Sponsor:

Leigh R. Hochberg, MD, PhD.

Location:

Boston, Stanford

Code:

NCT05724173

Conditions

Anarthria

Dysarthria

Tetraplegia

Spinal Cord Injuries

Amyotrophic Lateral Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

BrainGate Neural Interface System

Phase 1 Study of RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid Tumors

Recruiting
PHASE1

Sponsor:

Ribon Therapeutics, Inc.

Location:

Boston, New Haven, Pittsburgh, Nashvilleshow 6 more

Code:

NCT04053673

Conditions

Solid Tumor, Adult

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

RBN-2397

ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves

Recruiting

Sponsor:

Edwards Lifesciences

Location:

Boston, Ridgewood, New York, Morristownshow 25 more

Code:

NCT05172973

Conditions

Aortic Valve Insufficiency

Aortic Valve Stenosis

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

SAPIEN X4 THV

Individualized Functional Connectivity Targeting in AiTBS for Depression

Recruiting
PHASE2

Sponsor:

Brigham and Women's Hospital

Location:

Boston

Code:

NCT05680727

Conditions

Depressive Disorder, Major

Depression

Mood Disorders

Mental Disorder

Psychiatric Disorder

Eligibility Criteria

Sex: All

Age: 22 - 70+

Healthy Volunteers: Not accepted

Interventions

transcranial magnetic stimulation

GaitBetter: Motor and Cognitive Training for Gait Rehabilitation and Falls Prevention in Stroke Survivors.

Recruiting

Sponsor:

Spaulding Rehabilitation Hospital

Location:

Boston

Code:

NCT04625127

Conditions

Stroke

Gait, Hemiplegic

Hemiplegia

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Treadmill gait training with GaitBetter

Treadmill gait training with GaitBetter + Standard of care

Standard of care

SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors

Recruiting

Sponsor:

American Thrombosis and Hemostasis Network

Location:

Boston, New Hyde Park, Washington, Clevelandshow 19 more

Code:

NCT04647227

Conditions

Hemophilia A With Inhibitor

Hemophilia B With Inhibitor

Eligibility Criteria

Sex: All

Age: 12 - 70+

Healthy Volunteers: Not accepted

Interventions

coagulation factor VIIa [recombinant]-jncw

Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis

Recruiting
PHASE2

Sponsor:

Kowa Research Institute, Inc.

Location:

Boston, Montreal, Hershey, Greenbeltshow 42 more

Code:

NCT05327127

Conditions

NASH

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

K-877-ER

CSG452

Placebo

The Study Assessing the Safety and Efficacy of OK-101 Treatment in Subjects With Neuropathic Corneal Pain

Recruiting
PHASE2

Sponsor:

Okyo Pharma Ltd

Location:

Boston

Code:

NCT06637527

Conditions

Neuropathic Pain

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

OK-101 0.05%

OK-101 0.1%

Placebo

Study to Allow Patients Previously Participating in a Novartis Sponsored Trial to Continue Receiving Capmatinib Treatment as Single Agent or in Combination With Other Treatments or the Combination Treatment Alone

Recruiting
PHASE2

Sponsor:

Novartis Pharmaceuticals

Location:

Boston, Edmonton

Code:

NCT03040973

Conditions

Advanced Solid Tumors Which Are cMET-dependent

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Capmatinib

Nazartinib

Gefitinib

Osimertinib

With its world-renowned healthcare network and prestigious medical research institutions, Boston is a premier destination for a wide range of clinical trials. Major centers such as Massachusetts General Hospital, Brigham and Women’s Hospital, Beth Israel Deaconess Medical Center, and the Dana-Farber Cancer Institute lead groundbreaking studies across various medical fields. These institutions are at the forefront of innovation, making Boston a hub for cutting-edge clinical research.

Why choose Boston for clinical trials?

Common conditions studied in Boston

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Boston